文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

可解释机器学习模型用于脓毒症相关急性肾损伤分期预测的开发与验证

[Development and validation of an interpretable machine learning model for stage prediction of sepsis-associated acute kidney injury].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2026-01-01
一句话结论基于LightGBM的可解释模型可预测脓毒症患者7天内SA-AKI分期,内部验证AUC 0.872、外部验证AUC 0.851,24小时尿量是最重要特征。

LightGBM模型表现最佳,内部验证AUC 0.872、外部验证AUC 0.851,校准良好,DCA显示在阈值0.1-0.8(非AKI及AKI 2-3期)和0.1-0.4(AKI 1期)内净获益最高。SHAP分析显示24小时尿量在多数分期中重要性排名第一,为临床识别不同SA-AKI分期提供了可解释工具。

要点

  • 适用人群为MIMIC-IV和eICU-CRD数据库中成人脓毒症患者,以ICU入科为时间零点,用24小时内变量预测7天内AKI最高分期。
  • LightGBM为最佳模型,内部验证集预测SA-AKI分期的AUC为0.872,外部验证集为0.851,校准曲线良好。
  • 内部验证集预测非AKI及AKI 1、2、3期的AUC分别为0.909、0.837、0.838、0.904;外部验证集分别为0.837、0.818、0.815、0.937。
  • LASSO和有序Logistic回归筛选出13个特征,24小时尿量OR=0.183(95%CI 0.168-0.200,P<0.001)在多数分期SHAP重要性排名第一。
  • DCA显示非AKI及AKI 2、3期在阈值0.1-0.8内净获益最高,AKI 1期在阈值0.1-0.4内净获益最高。

适用人群与场景

  • MIMIC-IV数据库和eICU-CRD数据库中的成人脓毒症患者,以ICU入科为时间零点。
  • 提取ICU入科后24小时内的人口学数据、生命体征、实验室参数、器官功能评分和治疗干预变量。
  • 排除人群原文未提及。

诊断标准与关键阈值

  • 研究结局为ICU入科后7天内发生急性肾损伤(AKI)及其最高分期。
  • 采用LASSO回归和多变量有序Logistic回归筛选与SA-AKI分期相关的特征。
  • 基于AUC、准确率、F1分数、精确率、特异度和敏感度选择最优模型。

处置流程与药物剂量

  • 原文未提及

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 共筛选出13个特征:24小时尿量(OR=0.183,95%CI 0.168-0.200,P<0.001)、体重指数(OR=2.016,95%CI 1.887-2.155,P<0.001)、有创机械通气(OR=1.395,95%CI 1.315-1.478,P<0.001)、充血性心力衰竭(OR=1.405,95%CI 1.321-1.494,P<0.001)、男性(OR=1.088,95%CI 1.028-1.152,P=0.004)、
  • LightGBM为最佳模型,内部验证集和外部验证集预测SA-AKI分期的AUC分别为0.872和0.851。
  • 内部验证集预测非AKI及AKI 1、2、3期的AUC分别为0.909、0.837、0.838、0.904;外部验证集分别为0.837、0.818、0.815、0.937。
  • DCA显示非AKI及AKI 2、3期在阈值0.1-0.8内净获益最高,AKI 1期在阈值0.1-0.4内净获益最高。
  • SHAP分析显示24小时尿量在多数分期中重要性排名第一,外部验证集中非AKI患者最重要的特征为有创机械通气。

证据类型、等级与局限

  • 证据类型为回顾性队列研究,使用两个公开数据库进行模型开发和内外部验证。
  • 局限性:回顾性设计,原文未提及前瞻性验证;模型基于MIMIC-IV和eICU-CRD数据库,外推性需进一步验证。

对床旁实践的改变

  • 该模型可用于ICU入科24小时内识别脓毒症患者7天内发生不同AKI分期的风险,辅助个体化临床干预。
  • 24小时尿量是预测SA-AKI分期最重要的特征,提示床旁应准确记录尿量。
  • 模型为预测工具,原文未提供具体干预措施或治疗阈值,不能直接改变处置流程。
  • 适用人群为成人脓毒症患者,不适用于非脓毒症患者或儿童(原文未纳入)。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

OBJECTIVE: To develop a stage prediction model for sepsis-associated acute kidney injury (SA-AKI) based on interpretable machine learning, thereby providing support for individualized clinical intervention.

METHODS: Adult patients with sepsis were selected from the Medical Information Mart for Intensive Care-IV (MIMIC-IV) database and the eICU-Collaborative Research Database (eICU-CRD). Intensive care unit (ICU) admission was defined as time zero. Demographic data were extracted, along with clinical variables collected within 24 hours after ICU admission, including vital signs, laboratory parameters, organ function scores, and therapeutic interventions. The occurrence of acute kidney injury (AKI) and its highest stage within 7 days after ICU admission were used as the study outcomes. Data from the MIMIC-IV database were divided into training and internal validation sets in a 7 : 3 ratio, stratified by AKI stage, while data from eICU-CRD were used as the external validation set. LASSO regression and multivariable ordinal Logistic regression were used to select features associated with SA-AKI stage. Six machine learning models were developed, including eXtreme Gradient Boosting, Light Gradient Boosting Machine (LightGBM), random forest, K-nearest neighbors, support vector machine, and logistic regression. The optimal model was selected based on the area under the receiver operator characteristic curve (AUC), accuracy, F1-score, precision, specificity, and sensitivity. Calibration curve and decision curve analysis (DCA) were used to evaluate model performance, and SHapley Additive exPlanations (SHAP) were used to interpret the optimal model.

RESULTS: A total of 7 415 and 2 727 patients were included from the MIMIC-IV and eICU-CRD databases, respectively. Thirteen features were selected using LASSO regression and multivariable ordinal Logistic regression, including 24-hour urine output [odds ratio (OR)=0.183, 95% confidence interval (95%CI) was 0.168-0.200, P<0.001], body mass index (OR=2.016, 95%CI was 1.887-2.155, P<0.001), invasive mechanical ventilation (OR=1.395, 95%CI was 1.315-1.478, P<0.001), congestive heart failure (OR=1.405, 95%CI was 1.321-1.494, P<0.001), male (OR=1.088, 95%CI was 1.028-1.152, P=0.004), mean serum potassium level (OR=1.109, 95%CI was 1.044-1.178, P<0.001), mean activated partial thromboplastin time (OR=1.212, 95%CI was 1.141-1.288, P<0.001), maximum lactate level (OR=1.373, 95%CI was 1.282-1.470, P<0.001), mean body temperature (OR=0.875, 95%CI was 0.823-0.930, P<0.001), minimum pulse oxygen saturation (OR=0.811, 95%CI was 0.763-0.862, P<0.001), diabetes mellitus (OR=1.131, 95%CI was 1.067-1.199, P<0.001), maximum total bilirubin level (OR=1.345, 95%CI was 1.246-1.451, P<0.001), and vasoactive drug use (OR=1.160, 95%CI was 1.092-1.233, P<0.001). Compared with other models, LightGBM was identified as the best-performing model, and its predicted probabilities were well calibrated. The model achieved AUCs of 0.872 and 0.851 for predicting SA-AKI stage in the internal and external validation sets. In the internal validation set, the AUCs for predicting non-AKI and AKI stages 1, 2 and 3 were 0.909, 0.837, 0.838, and 0.904, respectively, while the corresponding AUCs in the external validation set were 0.837, 0.818, 0.815, and 0.937. The DCA results showed that the highest net benefit was achieved within a threshold range of 0.1-0.8 for patients with non-AKI and AKI stage 2 and stage 3, and within a threshold range of 0.1-0.4 for patients with AKI stage 1. Differences in feature importance across SA-AKI stages were revealed by SHAP analysis. The 24-hour urine output was ranked first in most stages, whereas invasive mechanical ventilation was identified as the most important feature among non-AKI patients in the external validation set.

CONCLUSIONS: The LightGBM-based model for predicting SA-AKI stages was successfully developed, and key features affecting each stage were identified using SHAP, providing an interpretable tool for the clinical identification of different SA-AKI stages.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Wang W, Shi A, Wang Y, et al. [Development and validation of an interpretable machine learning model for stage prediction of sepsis-associated acute kidney injury]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2026. PMID: 42693970. doi:10.3760/cma.j.cn121430-20260324-00137

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。